Investors must take note of Ultragenyx Pharmaceutical Inc.’s (RARE) performance last week, which was 1.91%.
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) kicked off on Monday, up 3.12% from the previous trading day, before settling in for the closing price of $42.37.